【结 构 式】 |
【分子编号】16810 【品名】methyl (Z)-3-[([(3S)-1-[amino(imino)methyl]piperidinyl]methyl)amino]-2-butenoate hydrochloride 【CA登记号】 |
【 分 子 式 】C12H23ClN4O2 【 分 子 量 】290.79308 【元素组成】C 49.57% H 7.97% Cl 12.19% N 19.27% O 11% |
合成路线1
该中间体在本合成路线中的序号:(VIII)A general synthesis of this entire class of thrombin inhibitors has been published recently. An alternative synthesis for the preparation of napsagatran is outlined in Scheme 21319301a: L-Aspartic acid is sulfonated with naphthalenesulfochloride to give the sulfonamide (I). Reaction of (I) with formaldehyde leads to the oxazolinone (II), which is reacted with N-cyclopropylglycine ethyl ester (III) to afford the aspartate (IV). Condensation of (IV) with the guanidine (IX) and saponification of the ethyl ester group provides napsagatran. For the preparation of the guanidine (IX), picolylamine is hydrogenated to give the racemic 3-aminomethyl-piperidine, from which the desired enantiomer (V) is isolated as dibenzoyltartrate by crystallization. Reaction of piperidine (V) with acetoacetate affords the protected piperidine (VI), which is amidinated with amidinotriazole (VII) to give the protected guanidine (VIII). Deprotection of (VIII) with hydrochloric acid provides the enantiomerically pure guanidine (IX) as dihydrochloride.
【1】 Banner, D.W.; Hilpert, K.; Ackermann, J.; et al.; Design and synthesis of potent and highly selective thrombin inhibitors. J Med Chem 1994, 37, 23, 3889-901. |
【2】 Gast, A.; Kirchhofer, D.; Soukup. M.; Roux, S.; Ackermann, J.; Hilpert, K.; Tschopp, T.B.; Schmid, G.; Napsagatran. Drugs Fut 1995, 20, 5, 476. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
12263 | Cyclopropylamine; Cyclopropanamine | 765-30-0 | C3H7N | 详情 | 详情 | |
13070 | L-Aspartic acid; (2S)-2-Aminobutanedioic acid | 56-84-8 | C4H7NO4 | 详情 | 详情 | |
16640 | Ethyl 2-bromoacetate; Ethyl bromoacetate | 105-36-2 | C4H7BrO2 | 详情 | 详情 | |
18731 | 3-pyridinylmethanamine; 3-pyridinylmethylamine | 3731-52-0 | C6H8N2 | 详情 | 详情 | |
(I) | 16803 | (2S)-2-[(2-naphthylsulfonyl)amino]butanedioic acid | C14H13NO6S | 详情 | 详情 | |
(II) | 16804 | 2-[(4S)-3-(2-naphthylsulfonyl)-5-oxo-1,3-oxazolan-4-yl]acetic acid | C15H13NO6S | 详情 | 详情 | |
(III) | 16805 | ethyl 2-(cyclopropylamino)acetate | C7H13NO2 | 详情 | 详情 | |
(IV) | 16806 | (3S)-4-[cyclopropyl(2-ethoxy-2-oxoethyl)amino]-3-[(2-naphthylsulfonyl)amino]-4-oxobutyric acid | C21H24N2O7S | 详情 | 详情 | |
(V) | 16807 | (3S)hexahydro-3-pyridinylmethylamine; (3S)hexahydro-3-pyridinylmethanamine | C6H14N2 | 详情 | 详情 | |
(VI) | 16808 | methyl (Z)-3-[[(3R)hexahydro-3-pyridinylmethyl]amino]-2-butenoate | C11H20N2O2 | 详情 | 详情 | |
(VII) | 16809 | 1H-1,2,4-triazole-1-carboximidamide hydrochloride | C3H6ClN5 | 详情 | 详情 | |
(VIII) | 16810 | methyl (Z)-3-[([(3S)-1-[amino(imino)methyl]piperidinyl]methyl)amino]-2-butenoate hydrochloride | C12H23ClN4O2 | 详情 | 详情 | |
(IX) | 16811 | (3S)-3-(aminomethyl)-1-piperidinecarboximidamide | C7H16N4 | 详情 | 详情 |